SK Chemical challenges to develop tetravalency influenza vaccine
(Yakup Shinmoon)
SK Chemical challenges to develop tetravalency influenza (flu) vaccine in preparation for potential pandemic flu virus mutations by the way of cell culture.
On Feb 7, SK Chemical announced that they received approval of clinical trial plan of tetravalency influenza vaccin...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
